Acute and clinically relevant drug-induced liver injury: a population based case-control study.

AIMS To provide quantitative information about the absolute and relative risks of acute and clinically relevant drug-induced liver injury. METHODS We performed a population-based case-control study using the UK-based General Practice Research Database as the source of information. A total of 1,636,792 persons subjects aged 5-75 years old registered in the database from 1 January, 1994 to 31 December, 1999 were followed-up for a total of 5,404,705 person-years. Cases were identified by an exhaustive computer search, then reviewed manually and finally validated against the clinical records. Only idiopathic cases serious enough to be referred to hospital or a consultant were selected. A total of 5000 controls were randomly sampled from the person-time of study cohort. Current users were defined if a prescription ended within 15 days of the index date, and nonusers if there was no prescription before the index date. RESULTS One hundred and twenty-eight patients were considered as valid cases, being the crude incidence rate of 2.4 (95% confidence interval: 2.0, 2.8) per 100 000 person-years. The strongest associations were found with chlorpromazine (adjusted odds ratio (AOR); 95% CI = 416; 45, 3840), amoxicillin/clavulanic acid (AOR = 94.8; 27.8, 323), flucloxacillin (AOR = 17.7; 4.4, 71.0), macrolides (AOR = 6.9; 2.3, 21.0), tetracyclines (AOR = 6.2; 2.4, 15.8); metoclopramide (AOR = 6.2; 1.8, 21.3); chlorpheniramine (AOR = 9.6; 1.9, 49.7); betahistine (AOR = 15.3; 2.9, 80.7); sulphasalazine (AOR = 25.5; 6.0, 109); azathioprine (AOR = 10.5; 1.4, 76.4), diclofenac (AOR = 4.1; 1.9, 8.8) and antiepileptics (AOR = 5.1; 1.9, 13.7). A dose-effect was apparent for diclofenac, amoxicillin/clavulanic acid and flucloxacillin. The combination of two or more hepatotoxic drugs increased the risk by a factor of 6. The highest crude incidence rates were found for chlorpromazine, azathioprine, and sulfasalazine (about 1 per 1000 users). CONCLUSIONS Idiopathic, acute and clinically relevant liver injury, which has the use of drugs as the most probable aetiology, is a rare event in the general population. The relative risks of 40 drugs/therapeutic classes are provided, along with the crude incidence rates for 15 of them where a statistical association was found.

[1]  S. Gutthann,et al.  The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. , 1993 .

[2]  R. Da Cas,et al.  Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs , 2003, BMJ : British Medical Journal.

[3]  P. Hillon,et al.  Incidence of drug‐induced hepatic injuries: A French population‐based study , 2002, Hepatology.

[4]  L. G. García Rodríguez,et al.  Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. , 1994, Archives of internal medicine.

[5]  H. Jick,et al.  A Review of Epidemiologic Research on Drug‐Induced Acute Liver Injury Using the General Practice Research Data Base in the United Kingdom , 1997, Pharmacotherapy.

[6]  X. Vidal,et al.  Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. , 2002, Journal of hepatology.

[7]  Shivakumar Chitturi,et al.  Drug-induced liver disease , 2000 .

[8]  H. Jick,et al.  Cholestatic Hepatitis Associated with Flucloxacillin , 1993, The Medical journal of Australia.

[9]  R. N. Macsween,et al.  Co-amoxiclav jaundice: clinical and histological features and HLA class II association , 2000, Gut.

[10]  K. Reddy,et al.  Hepatotoxicity of Psychotropic Drugs and Drugs of Abuse , 2002 .

[11]  G. Screaton,et al.  Drugs acting on the immune system , 2003 .

[12]  S. Gutthann,et al.  Use of the UK General Practice Research Database for pharmacoepidemiology. , 1998, British journal of clinical pharmacology.

[13]  H. Jick,et al.  Liver Disorders in Patients Receiving Chlorpromazine or Isoniazid , 1993, Pharmacotherapy.

[14]  J. Brogard,et al.  Antibacterials and Antifungal Agents , 2002 .

[15]  Andrew Bate,et al.  Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions , 2003, International clinical psychopharmacology.

[16]  B. Stricker,et al.  Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. , 1996, Archives of internal medicine.

[17]  R. Schlienger,et al.  Association between body mass index and liver disorders: an epidemiological study. , 2002, Journal of hepatology.

[18]  H. Friis,et al.  Drug‐induced hepatic injury: an analysis of 1100 cases reported to The Danish Committee on Adverse Drug Reactions between 1978 and 1987 , 1992, Journal of internal medicine.

[19]  L. Lasagna,et al.  Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective , 1995, Clinical pharmacology and therapeutics.

[20]  M. Cook,et al.  Sulpiride-induced cholestalic jaundice. , 1996, The Australian and New Zealand journal of psychiatry.

[21]  C. Bénichou.  Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.

[22]  B. H. Ch. Stricker,et al.  Drug-induced Hepatic Injury , 1985 .